Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Gold

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Journal of Behavioral Addictions|October 16, 2014
Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubricKenneth Blum, Marcelo Febo, Thomas McLaughlin, et al.
Biological Psychiatry|September 20, 2005
Severe deficit in brain reward function associated with fentanyl withdrawal in ratsAdrie W Bruijnzeel, Ben Lewis, Lakshmi K Bajpai, et al.
Frontiers in Bioscience (Landmark Edition)|April 15, 2017
Substance use disorder a bio-directional subset of reward deficiency syndromeKenneth Blum, Mark Gold, Zsolt Demetrovics, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|September 30, 2008
Toxicity in rhesus monkeys following administration of the 8-aminoquinoline 8-[(4-amino-l-methylbutyl)amino]- 5-(l-hexyloxy)-6-methoxy-4-methylquinoline (WR242511)Gary Rockwood, Steven Duniho, Crystal Briscoe, et al.
Anesthesia and Analgesia|September 27, 2006
Dexmedetomidine does not increase the incidence of intracarotid shunting in patients undergoing awake carotid endarterectomyAlex Bekker, Mark Gold, Raza Ahmed, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 28, 2021
Chronic neuroleptic treatment combined with a high fat diet elevated [3H] flunitrazepam binding in the cerebellumBrittany Richardson, Sabrina Swenson, John Hamilton, et al.
Journal of Psychoactive Drugs|May 31, 2012
Sex, drugs, and rock 'n' roll: hypothesizing common mesolimbic activation as a function of reward gene polymorphismsKenneth Blum, Tonia Werner, Stefanie Carnes, et al.
Journal of Genetic Syndromes & Gene Therapy|March 14, 2013
Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric SurgeryKenneth Blum, John Bailey, Anthony M Gonzalez, et al.
Oncotarget|March 19, 2016
Dopamine D2 gene expression interacts with environmental enrichment to impact lifespan and behaviorPanayotis K Thanos, John Hamilton, Joseph R O'Rourke, et al.
Journal of Neurosurgical Anesthesiology|March 17, 2004
Dexmedetomidine for awake carotid endarterectomy: efficacy, hemodynamic profile, and side effectsAlex Y Bekker, John Basile, Mark Gold, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Behavioral Addictions|October 16, 2014
Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubricKenneth Blum, Marcelo Febo, Thomas McLaughlin, et al.
Biological Psychiatry|September 20, 2005
Severe deficit in brain reward function associated with fentanyl withdrawal in ratsAdrie W Bruijnzeel, Ben Lewis, Lakshmi K Bajpai, et al.
Frontiers in Bioscience (Landmark Edition)|April 15, 2017
Substance use disorder a bio-directional subset of reward deficiency syndromeKenneth Blum, Mark Gold, Zsolt Demetrovics, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|September 30, 2008
Toxicity in rhesus monkeys following administration of the 8-aminoquinoline 8-[(4-amino-l-methylbutyl)amino]- 5-(l-hexyloxy)-6-methoxy-4-methylquinoline (WR242511)Gary Rockwood, Steven Duniho, Crystal Briscoe, et al.
Anesthesia and Analgesia|September 27, 2006
Dexmedetomidine does not increase the incidence of intracarotid shunting in patients undergoing awake carotid endarterectomyAlex Bekker, Mark Gold, Raza Ahmed, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 28, 2021
Chronic neuroleptic treatment combined with a high fat diet elevated [3H] flunitrazepam binding in the cerebellumBrittany Richardson, Sabrina Swenson, John Hamilton, et al.
Journal of Psychoactive Drugs|May 31, 2012
Sex, drugs, and rock 'n' roll: hypothesizing common mesolimbic activation as a function of reward gene polymorphismsKenneth Blum, Tonia Werner, Stefanie Carnes, et al.
Journal of Genetic Syndromes & Gene Therapy|March 14, 2013
Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric SurgeryKenneth Blum, John Bailey, Anthony M Gonzalez, et al.
Oncotarget|March 19, 2016
Dopamine D2 gene expression interacts with environmental enrichment to impact lifespan and behaviorPanayotis K Thanos, John Hamilton, Joseph R O'Rourke, et al.
Journal of Neurosurgical Anesthesiology|March 17, 2004
Dexmedetomidine for awake carotid endarterectomy: efficacy, hemodynamic profile, and side effectsAlex Y Bekker, John Basile, Mark Gold, et al.
Pageof 5